Tasuku Honjo

Tasuku Honjo is a renowned Japanese immunologist and molecular biologist who has made significant contributions to the field of cancer research. He is best known for his discovery of the PD-1 gene, which has led to the development of immune checkpoint therapies, such as Nivolumab and Pembrolizumab, used to treat various types of cancer, including Melanoma, Lung cancer, and Renal cell carcinoma. His work has been recognized internationally, and he has collaborated with prominent researchers, including James Allison, Carl June, and Zelig Eshhar. Honjo's research has been supported by organizations such as the Japanese Ministry of Education, Culture, Sports, Science and Technology, the Japan Society for the Promotion of Science, and the Bill and Melinda Gates Foundation.

● Early Life and Education

Tasuku Honjo was born on January 27, 1942, in Kyushu, Japan, and grew up in a family of Kyoto University professors. He developed an interest in Biology and Chemistry at an early age, inspired by his parents and educators, including Hideki Yukawa and Tomonaga Shin'ichirō. Honjo pursued his undergraduate studies at Kyoto University, where he earned his Bachelor of Science degree in Biology in 1966. He then moved to the United States to pursue his graduate studies at Worcester Foundation for Experimental Biology and Carnegie Institution of Washington, working under the guidance of renowned scientists, including Barbara McClintock and Alfred Hershey. Honjo received his Ph.D. in Molecular biology from Carnegie Institution of Washington in 1975.

● Career

After completing his graduate studies, Honjo returned to Japan and joined the faculty of Kyoto University as an assistant professor in the Department of Genetics. He quickly rose through the ranks, becoming a full professor in 1984, and later served as the chairman of the Department of Medical Chemistry from 1992 to 2000. During his tenure at Kyoto University, Honjo established a research laboratory focused on Immunology and Molecular biology, where he investigated the mechanisms of immune responses and developed novel therapies for Cancer and autoimmune diseases. He has also held visiting professorships at prestigious institutions, including Stanford University, Harvard University, and University of California, San Francisco, and has collaborated with researchers at National Institutes of Health, European Molecular Biology Laboratory, and Wellcome Trust Sanger Institute.

● Research and Discoveries

Tasuku Honjo's research has centered on the discovery of novel genes and pathways involved in immune responses and Cancer development. His laboratory has made significant contributions to the understanding of PD-1 and its role in immune checkpoint regulation. Honjo's discovery of the PD-1 gene in 1992 has led to the development of immune checkpoint therapies, which have revolutionized the treatment of various types of Cancer. His research has also explored the mechanisms of T cell activation and regulation, and has identified novel targets for Cancer immunotherapy, including CTLA-4 and LAG-3. Honjo's work has been published in top-tier scientific journals, including Nature, Science, and Cell, and has been recognized by awards from organizations such as the American Association for Cancer Research, American Society of Clinical Oncology, and European Society for Medical Oncology.

● Awards and Honors

Tasuku Honjo has received numerous awards and honors for his contributions to cancer research and Immunology. He was awarded the Tang Prize in 2014, the Breakthrough Prize in Life Sciences in 2015, and the Nobel Prize in Physiology or Medicine in 2018, along with James Allison, for their discovery of cancer therapy by inhibition of immune checkpoints. Honjo has also received awards from the Japanese government, including the Order of Culture and the Person of Cultural Merit award, and has been recognized by international organizations, such as the National Academy of Sciences, Royal Society, and French Academy of Sciences. He has also been awarded honorary degrees from universities such as Harvard University, University of Oxford, and University of Cambridge.

● Personal Life

Tasuku Honjo is married to Shigeko Honjo, and they have two children, Yoshihiro Honjo and Emiko Honjo. He is known for his dedication to his research and his passion for science education. Honjo has been involved in various initiatives to promote science education and cancer awareness in Japan and internationally, and has served as a mentor to numerous students and young researchers, including Takashi Tsukamoto and Hiroyuki Nishida. He is also a member of various scientific organizations, including the Japanese Society for Immunology, American Association of Immunologists, and International Union of Immunological Societies. Category:Japanese scientists